4//SEC Filing
Berger Dietmar 4
Accession 0001209191-19-008518
CIK 0001604464other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:26 PM ET
Size
7.4 KB
Accession
0001209191-19-008518
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Award
Common Stock
2019-02-06+25,000→ 75,000 total - Award
Employee Stock Option (Right to Buy)
2019-02-06+50,000→ 50,000 totalExercise: $38.47Exp: 2029-02-05→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service.
- [F2]1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001739515
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:26 PM ET
- Size
- 7.4 KB